Riskpilot← Back to searchSign inGet full accessSANDVIKA NEVROSENTER AS
ASActiveOrg 916603290Sandviksveien 178, 1337 SandvikaMedical specialists activities · NACE 8622Est. 201616 employeeswww.sandvikanevrosenter.no
Revenue 2024
NOK 64,5M
+73% vs 2022
EBITDA margin
11.4%
+151% vs 2022
Equity ratio
63.1%
Financial strength
Net profit 2024
NOK 5,8M
+194% vs 2022
| Revenue | NOK 64,5M | +73% |
| EBITDA | NOK 7,4M | +151% |
| Net profit | NOK 5,8M | +194% |
| Total assets | NOK 21,9M | +39% |
| Equity | NOK 13,8M | +21% |
| Employees | 16 | — |
Legal name
SANDVIKA NEVROSENTER AS
Org number
916603290
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
21. januar 2016
Share capital
NOK 30 000
Employees
16 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Selskapets formål er spesialist- og allmennlegevirksomhet, herunder konsulent- virksomhet og deltakelse i forskning, og dertil hørende virksomhet, herunder deltakelse i selskaper med lignende formål.
Address
Sandviksveien 178, 1337 Sandvika
Website
www.sandvikanevrosenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|
| Revenue | 32 228 | 33 733 | 36 152 | 37 186 | 64 459 |
| Staff expenses | −14 480 | −14 116 | −15 231 | −15 190 | −23 692 |
| EBITDA | 2 982 | 3 203 | 2 875 | 2 936 | 7 371 |
| Depreciation & amort. | −528 | −536 | −475 | −445 | −285 |
| EBIT | 2 454 | 2 668 | 2 400 | 2 492 | 7 086 |
| Net financials | 35 | 17 | 0 | 55 | 390 |
| Profit before tax | 2 489 | 2 685 | 2 400 | 2 546 | 7 476 |
| Tax | 550 | 591 | 528 | 560 | 1 646 |
| Net profit | 1 939 | 2 094 | 1 872 | 1 986 | 5 830 |
| Item | 2019 | 2020 | 2021 | 2022 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 611 | 11 578 | 13 799 | 15 735 | 21 921 |
| Equity | 5 510 | 7 603 | 9 475 | 11 461 | 13 827 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 101 | 3 975 | 4 324 | 4 274 | 8 093 |
| Total debt | 5 101 | 3 975 | 4 324 | 4 274 | 8 093 |
EBITDA margin
11.4%
This company
15.8%
Market median
-28% vs market
20192024
Equity ratio
63.1%
This company
38.2%
Market median
+65% vs market
20192024
Return on equity
42.2%
This company
18.4%
Market median
+129% vs market
20192024
Net profit margin
9.0%
This company
8.1%
Market median
+11% vs market
20192024
Asset turnover
2.94×
This company
1.12×
Market median
+162% vs market
20192024
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2024-06-30
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MS Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Former (4) | ||
| Board of Directors | 2020 – 2023 | |
| Chairman | 2020 – 2023 | |
| Chairman | 2023 – 2024 | |
| Board of Directors | 2020 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 | |
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lhl
SANDVIKA NEVROSENTER AS Board members of SANDVIKA NEVROSENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marte Swakhoven | Chief Executive Officer | 0 companies |
| Hege Marie Stangnes | Board of Directors | 0 companies |
| Per Helge Moe Fagermoen | Chairman | 0 companies |
| Fredrik Mørch-Reiersen | Board of Directors | 0 companies |
| Håvard Selby Ebbestad | Chairman | 0 companies |
| Per Helge Fagermoen | Chairman | 0 companies |
| Rune Hagerup | Board of Directors | 0 companies |